EU Decision Time For Orphans Acoramidis, Garadacimab & Imetelstat, Plus 10 Other Products

Sponsors of 13 new products, including BridgeBio’s acoramidis, could soon learn whether or not the European Medicines Agency recommends their drugs for pan-EU marketing approval.